Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.68 USD
Change Today +0.15 / 4.25%
Volume 127.7K
As of 5:20 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven J. Mento Ph.D.

Co-Founder, Chief Executive Officer, President and Director,Conatus Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 121 board members in 3 different organizations across 4 different industries.

See Board Relationships
63$3,674,410
As of Fiscal Year 2014

Background*

Dr. Steven J. Mento, Ph.D., Co-founded Conatus Pharmaceuticals Inc. in 2005 and has been its Chief Executive Officer and President since July 2005. Dr. Mento has over twenty years of combined experience in the biotechnology and pharmaceutical industry, ten of which served as President and Chief Executive Officer. Dr Steven served as the President and Chief Executive Officer of IDUN Pharmaceuticals, Inc. from August 1997 to 2005. Dr. Mento joined Idun in 1997. From 1982 ...

Read Full Background

Corporate Headquarters*

16745 West Bernardo Drive
San Diego, California 92121

United States

Phone: 858-376-2600
Fax: --

Board Members Memberships*

Director
2005-Present
Director and Chairman of Compensation Committee
2005-Present
Co-Founder, Chief Executive Officer, President and Director

Education*

MS
Rutgers, The State University of New Jersey
PhD
Rutgers, The State University of New Jersey
BA
Rutgers, The State University of New Jersey

Other Affiliations*

Annual Compensation*

Salary$460,000
Total Annual Compensation$460,000

Stock Options*

All Other Compensation$15,850
Exercisable Options248,484
Exercisable Options Value$1,484,298
Total Value of Options$1,484,298
Total Number of Options648,484

Total Compensation*

Total Annual Cash Compensation$590,850
Total Short Term Compensation$460,000
Other Long Term Compensation$15,850
Total Calculated Compensation$3,674,410
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CNAT:US $3.68 USD +0.15

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CONATUS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.